Upstream Process Intensification
-
The CHO Toolkit: Flexible Solutions For Complex Molecules
9/11/2025
A modular cell line development platform helps overcome biologic complexity. Learn how flexibility and expert support drive success from early development through commercial manufacturing.
-
Meet The Experts: Part 2 - Raman Spectroscopy
5/1/2023
Watch part 2 of this 4-part interview series to explore Raman spectroscopy, one of the main PAT tools for monitoring bioprocess CQAs and CPPs, with expert Fabien Caron.
-
Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities
11/2/2018
Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.
-
A New Era Of mAb Manufacturing
6/16/2025
A medium and feed system designed to help you accelerate your work in bioprocessing and get to market faster.
-
A Collaboration With Zurich University Of Applied Sciences
5/19/2025
Explore ZHAW’s pioneering work and collaboration in cell cultivation and bioprocessing to deliver scalable, high-performance solutions that address key challenges in biomanufacturing scale-up.
-
Applications For PAT And Continuous: Seed Trains & Data Anomalies
12/13/2022
Paul Testa, EVP of Supply Chain and Operations at Kyowa Kirin North America and Barrett Fallentine, Director, Process & Product Development at Pharmatech Associates discuss applications for continuous manufacturing and take an audience question on PAT data anomalies during the Bioprocess Online Live event Biopharma PAT: Gateway To Continuous Manufacturing.
-
How To Best Manage And Remove Aggregates From Your mAb Process?
2/14/2017
Aggregates in mAb therapeutics pose a risk to patients. Are you considering how best to manage and remove aggregates across your template?
-
Q&A On Continuous Manufacturing In Biopharma
12/13/2022
Paul Testa, EVP of Supply Chain and Operations at Kyowa Kirin North America and Barrett Fallentine, Director, Process & Product Development at Pharmatech Associates tackle questions from the audience to wrap up the Bioprocess Online Live event Biopharma PAT: Gateway To Continuous Manufacturing.
-
How Do We Quantify Continuous Manufacturing Benefits?
12/13/2022
In this segment of the Bioprocess Online Live event Biopharma PAT: Gateway To Continuous Manufacturing, Paul Testa, EVP of Supply Chain and Operations at Kyowa Kirin North America and Barrett Fallentine, Director, Process & Product Development at Pharmatech Associates cover the intended, expected, and actual outcomes of continuous manufacturing initiatives in biopharma. They also tackle audience questions on modality-specific benefits of continuous manufacturing, and how much those benefits cross over from one product to the next.
-
The Future Of Biomanufacturing: Innovating Process Intensification Together
7/1/2025
Redefine your biomanufacturing by advancing process intensification technologies through strategic planning, innovation, and close customer collaboration to drive scalable and efficient solutions.